Clinical Trial Update: BIOCHROMADERM® PMCF STUDY

View source ↗

Summary

Clinical PMCF study for BIOCHROMADERM is currently recruiting to evaluate nipple-areola complex reconstruction after mastectomy in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Laboratoires BIOTIC Phocea | Conditions: Reconstruction of the Nipple-areola Complex in Patients Undergoing Breast Reconstructive Surgery Following Mastectomy | Status: RECRUITING